Target intelligence / Profile preview

TearGlyde reconditioning system

Molecular classification
Other
01

Overview

TearGlyde reconditioning system is a proprietary component included in multipurpose contact lens cleaning solutions such as OPTI-FREE Replenish. It is a dual-action system containing components like Tetronic 1304 (a poloxamine surfactant) and nonanoyl ethylenediaminetriacetic acid (C9-ED3A), which adsorb to the surface and matrix of soft contact lenses (including silicone hydrogels) to maintain a thin, continuous layer of moisture on the lens throughout the day[2][3][5][6][9]. The system works synergistically with natural tear components to enhance lens wettability and wearer comfort by reducing friction and dryness[3][6]. It is not a molecular therapeutic target, receptor, or enzyme, and has no recognized role as a disease biomarker or point of interaction for pharmacological agents. TearGlyde reconditioning system is a formulation technology, not a drug target or biological entity. The entry is incorrect as a "target molecule/receptor" and should be flagged for exclusion from structured databases of molecular targets[2][3][5][6][9].

Other names
TearGlydeTearGlyde®

Beyond the preview

Go deeper on TearGlyde reconditioning system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TearGlyde reconditioning system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call